X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank60
3Y CAGR+3.1%
5Y CAGR-12.5%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+3.1%/yr
vs +32.2%/yr prior
5Y CAGR
-12.5%/yr
Recent acceleration
Acceleration
-29.2pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.91 | -86.4% |
| 2024 | 6.66 | +128.2% |
| 2023 | 2.92 | +251.9% |
| 2022 | 0.83 | +4.8% |
| 2021 | 0.79 | -55.4% |
| 2020 | 1.77 | +87.8% |
| 2019 | 0.94 | +248.2% |
| 2018 | 0.27 | -48.4% |
| 2017 | 0.53 | +188.9% |
| 2016 | -0.59 | - |